Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease - PubMed (original) (raw)
Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease
Hiroshi T Ichikawa et al. J Immunol. 2002.
Abstract
Some autoreactive T cells normally escape thymic selection and persist in the periphery. This is true of myelin-reactive CD4(+) T cells, the effectors of experimental autoimmune encephalomyelitis (EAE) in laboratory animals and the presumed mediators of multiple sclerosis in humans. Nonetheless, most individuals do not succumb to autoimmune disease. There is growing evidence that while peripheral APCs stimulate immune responses against foreign Ags in the setting of tissue destruction and "danger," they actually maintain tolerance against self Ags under steady state conditions. We hypothesized that tolerance against candidate autoantigens could be reversed by activation of APCs via CD40 or Toll-like receptor 9 signaling. Adult SJL mice injected i.p. with a peptide fragment of proteolipid protein (a candidate autoantigen in multiple sclerosis) emulsified in IFA fail to mount lymphoproliferative or cytokine responses and are protected from EAE upon subsequent challenge with the Ag combined with adjuvants. Here we report that tolerized proteolipid protein-specific lymph node cells regain the ability to divide, differentiate along a Th1 lineage, and transfer EAE when reactivated in the presence of agonistic Abs against CD40 or CpG oligonucleotides. The effects of both anti-CD40 and CpG oligonucleotides are dependent upon induction of IL-12. Our findings suggest two mechanisms to explain the well-documented association between infectious illnesses and flare-ups of multiple sclerosis. Microbial pathogens could 1) release molecules that bind Toll-like receptors, and/or 2) stimulate microbe-specific T cells to express CD40 ligand, thereby licensing APCs that bear both microbial and autoantigens to break tolerance.
Similar articles
- Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.
Bischof F, Hofmann M, Schumacher TN, Vyth-Dreese FA, Weissert R, Schild H, Kruisbeek AM, Melms A. Bischof F, et al. J Immunol. 2004 Mar 1;172(5):2878-84. doi: 10.4049/jimmunol.172.5.2878. J Immunol. 2004. PMID: 14978089 - Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
Chang TT, Kuchroo VK, Sharpe AH. Chang TT, et al. Curr Dir Autoimmun. 2002;5:113-30. doi: 10.1159/000060550. Curr Dir Autoimmun. 2002. PMID: 11826754 Review. No abstract available. - T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.
Kuchroo VK, Anderson AC, Waldner H, Munder M, Bettelli E, Nicholson LB. Kuchroo VK, et al. Annu Rev Immunol. 2002;20:101-23. doi: 10.1146/annurev.immunol.20.081701.141316. Epub 2001 Oct 4. Annu Rev Immunol. 2002. PMID: 11861599 Review.
Cited by
- Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis.
Radstake TR, van Lieshout AW, van Riel PL, van den Berg WB, Adema GJ. Radstake TR, et al. Ann Rheum Dis. 2005 Nov;64(11):1532-8. doi: 10.1136/ard.2004.033779. Epub 2005 May 5. Ann Rheum Dis. 2005. PMID: 15878905 Free PMC article. Review. - Mucosal delivery of CpG oligodeoxynucleotides expands functional dendritic cells and macrophages in the vagina.
Sajic D, Patrick AJ, Rosenthal KL. Sajic D, et al. Immunology. 2005 Feb;114(2):213-24. doi: 10.1111/j.1365-2567.2004.02081.x. Immunology. 2005. PMID: 15667566 Free PMC article. - Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells.
Li Y, Heuser JS, Kosanke SD, Hemric M, Cunningham MW. Li Y, et al. Am J Pathol. 2005 Jul;167(1):5-15. doi: 10.1016/S0002-9440(10)62948-3. Am J Pathol. 2005. PMID: 15972947 Free PMC article. - Eosinophils in Autoimmune Diseases.
Diny NL, Rose NR, Čiháková D. Diny NL, et al. Front Immunol. 2017 Apr 27;8:484. doi: 10.3389/fimmu.2017.00484. eCollection 2017. Front Immunol. 2017. PMID: 28496445 Free PMC article. Review. - Co-administration of CD40 agonistic antibody and antigen fails to overcome the induction of oral tolerance.
Chung Y, Kim DH, Lee SH, Kang CY. Chung Y, et al. Immunology. 2004 Jan;111(1):19-26. doi: 10.1111/j.1365-2567.2004.01787.x. Immunology. 2004. PMID: 14678195 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous